Loyola Enrolling Patients in Clinical Trial Using PET Scans to Diagnose Alzheimer’s

Loyola Enrolling Patients in Clinical Trial Using PET Scans to Diagnose Alzheimer’s
Loyola Medicine will participate in a landmark $100 million study called “Imaging Dementia – Evidence for Amyloid Scanning (IDEAS)” to evaluate the effectiveness of using positron emission tomography (PET) scans to detect Alzheimer’s disease (AD). The IDEAS (NCT02420756) study is based on the rationale that because clumps of amyloid proteins, which block signals in the brain, have been

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

2 comments

    • Tim Bossie says:

      Hi Linda, you will have to talk with your doctor about the possibility of taking place in this study and if it is available in your area.

Leave a Comment

Your email address will not be published. Required fields are marked *